Buscar
01/06/2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
Arriola, E, Gonzalez-Cao, M, Domine, M, De Castro, J, Cobo, M, Bernabe, R, Navarro, A, Sullivan, I, Trigo, JM, Mosquera, J, Crama, L, Isla, D. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Oncology And Therapy. 2022; 10(1)DOI:10.1007/s40487-021-00182-0. PMID:35032007. IF:(Q/D).
01/04/2022
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021)
Remon, J, Bernabe, R, Diz, P, Felip, E, Gonzalez-Larriba, JL, Lazaro, M, Mielgo-Rubio, X, Sanchez, A, Sullivan, I, Massutti, B. SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021). Clinical & Translational Oncology. 2022; 24(4)DOI:10.1007/s12094-022-02788-w. PMID:35122634. IF:3.400(Q3/6D).
01/04/2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Capdevila, J, Gomez, MA, Guillot, M, Paez, D, Pericay, C, Safont, MJ, Tarazona, N, Vera, R, Vidal, J, Sastre, J. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021). Clinical & Translational Oncology. 2022; 24(4)DOI:10.1007/s12094-022-02816-9. PMID:35303269. IF:3.400(Q3/6D).
01/04/2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
Palassini, E, Mir, O, Grignani, G, Vincenzi, B, Gelderblom, H, Sebio, A, Valverde, C, Baldi, GG, Brunello, A, Cardellino, GG, Marrari, A, Badalamenti, G, Martin-Broto, J, Ferraresi, V, Libertini, M, Turano, S, Gataa, I, Collini, P, Dei Tos, AP, Gennaro, M, Bini, F, Provenzano, S, Lo Vullo, S, Mariani, L, Le Cesne, A, Casali, PG. Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses. BREAST CANCER RESEARCH AND TREATMENT. 2022; 192(3)DOI:10.1007/s10549-022-06524-4. PMID:35150367. IF:3.800(Q2/5D).